可商量
发表于 2025-3-23 12:44:14
Frank Salewski number of protocols.With both new and well established techAntibodies are indispensable tools for research, diagnosis, and therapy. Recombinant approaches allow the modification and improvement of nearly all antibody properties, such as affinity, valency, specificity, stability, serum half-life, ef
相互影响
发表于 2025-3-23 15:52:21
http://reply.papertrans.cn/43/4262/426169/426169_12.png
Inoperable
发表于 2025-3-23 18:30:32
Frank Salewski number of protocols.With both new and well established techAntibodies are indispensable tools for research, diagnosis, and therapy. Recombinant approaches allow the modification and improvement of nearly all antibody properties, such as affinity, valency, specificity, stability, serum half-life, ef
arterioles
发表于 2025-3-23 23:45:24
http://reply.papertrans.cn/43/4262/426169/426169_14.png
装勇敢地做
发表于 2025-3-24 05:01:39
Frank Salewskintibody properties, such as affinity, valency, specificity, stability, serum half-life, effector functions, and immunogenicity."Antibody Engineering" provides a comprehensive toolbox covering the well-established basics but also many exciting new techniques. The protocols reflect the latest "hands o
libertine
发表于 2025-3-24 10:26:46
Frank Salewskintibody properties, such as affinity, valency, specificity, stability, serum half-life, effector functions, and immunogenicity."Antibody Engineering" provides a comprehensive toolbox covering the well-established basics but also many exciting new techniques. The protocols reflect the latest "hands o
Mutter
发表于 2025-3-24 12:59:49
http://reply.papertrans.cn/43/4262/426169/426169_17.png
Enliven
发表于 2025-3-24 15:03:09
http://reply.papertrans.cn/43/4262/426169/426169_18.png
GUILE
发表于 2025-3-24 22:02:50
Bestandsaufnahme und hierarchischer Ansatz,chungen und entsprechen nicht der aus Anwendersicht erforderlichen Abbildung des Problems. Ziel dieses Kapitels ist es, die Voraussetzungen für eine zweckadäquate und die Problemstellung geeignet repräsentierende Darstellung zu schaffen.
myopia
发表于 2025-3-25 01:04:32
http://reply.papertrans.cn/43/4262/426169/426169_20.png